MedTrace Logo

Effects of HIIT on Metabolic Syndrome

NCT04133129 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2019-10-21

No results posted yet for this study

Summary

The project aims to find out the differences between two different types of structured training interventions have on the lipid profile of persons with diagnosed dyslipidemia. Each training intervention will last for 12 weeks. Subjects participating in the project will undergo a series of tests before and after the training intervention which will allow us to make conclusions.

Conditions

  • Dyslipidemias
  • Metabolic Syndrome
  • Sedentary Behavior
  • Obesity
  • Blood Pressure

Interventions

BEHAVIORAL

Low Volume-High Intensity Interval Training

On a treadmill, a 2 minute warm-up will be followed by 2 bouts of 4 minutes at an intensity between 85% and 95% of Maximum Heart Rate (HRmax) interspersed by a 2 minutes recovery bout at 70% of heart rate max, followed by a 3 minutes Cool Down

BEHAVIORAL

Moderate Intensity Continuous Training

On a treadmill,a 2-minute warm-up will be followed by 45 minutes at 65%-75% of Heart Rate max followed by 3 minutes cool down.

Sponsors & Collaborators

  • INGESPORT HEALTH AND SPA CONSULTING SL

    collaborator UNKNOWN

  • Coventry University

    lead OTHER

Principal Investigators

  • Elizabeth Horton, PhD · Coventry University

  • Alfonso Jimenez, PhD · GOfit and Sheffield Hallam University

  • Ismael Serrablo, MSc · Coventry University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-11-01
Primary Completion
2020-03-02
Completion
2020-03-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04133129 on ClinicalTrials.gov